WDIY Headlines

FDA Amends Emergency Use Authorization for OraSure's InteliSwab COVID-19 Test | WDIY Local News

WDIY | By Sarit Laschinsky
Published November 3, 2021 at 4:38 PM EDT
  • Facebook
  • Twitter
  • LinkedIn
  • Email

Your browser doesn’t support HTML5 audio
InteliSwab COVID-19 Rapid Test.
InteliSwab

The US Food and Drug Administration has amended its emergency use authorization for OraSure’s InteliSwab COVID-19 rapid test. WDIY’s Sarit Laschinsky has more.

(Original air-date: 11/2/21)

WDIY HeadlinesOraSureInteliSwabCOVID-19Delta VariantFood and Drug Administrationemergency use authorizationBethlehemLocal News
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Sarit Laschinsky
Sarit "Siri" Laschinsky was WDIY's News and Public Affairs Director until 2023.
See stories by Sarit Laschinsky
Related Content
  1. OraSure Receives $109 Million to Ramp Up COVID-19 Test Manufacturing | WDIY Local News
  2. OraSure Technologies Awarded $205 Million Contract for COVID-19 Tests | WDIY Local News